A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Certain additives found in ultra-processed foods are linked to increased type 2 diabetes risk, a new study finds. The mixtures are typically present in broths, dairy desserts, fats, sauces, and sugary ...

What if I told you there’s a wall at the edge of our solar system? 😱🚀 Scientists have detected a mysterious cosmic boundary ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Neuroscientists at Virginia Tech’s Fralin Biomedical Research Institute at VTC will investigate how obesity influences brain ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Periodically, this column is comprised of short health tips that don’t warrant a whole column of their own. From the spring ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Studies have also shown that sweeteners can stimulate the same neurons as the appetite hormone, leptin. Over time, this could ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...